PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,737 | -98.3% | 265 | -97.8% | 0.00% | – |
Q2 2023 | $157,202 | -78.0% | 11,991 | -81.3% | 0.00% | -100.0% |
Q1 2023 | $715,464 | +89.2% | 63,995 | +42.6% | 0.00% | – |
Q4 2022 | $378,187 | +1790.9% | 44,862 | +3626.1% | 0.00% | – |
Q3 2022 | $20,000 | -52.4% | 1,204 | -57.6% | 0.00% | – |
Q2 2022 | $42,000 | +7.7% | 2,837 | +79.0% | 0.00% | – |
Q1 2022 | $39,000 | -82.8% | 1,585 | -77.6% | 0.00% | – |
Q4 2021 | $227,000 | +57.6% | 7,089 | +77.6% | 0.00% | – |
Q3 2021 | $144,000 | +108.7% | 3,991 | +153.4% | 0.00% | – |
Q2 2021 | $69,000 | +97.1% | 1,575 | +104.5% | 0.00% | – |
Q1 2021 | $35,000 | -76.8% | 770 | -64.8% | 0.00% | – |
Q4 2020 | $151,000 | – | 2,186 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |